Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Cessation of drug use in chronic opiate abusers produces a severe withdrawal syndrome that is highly aversive, and avoidance of withdrawal or associated stimuli is a major factor contributing to opiate abuse. Increased noradrenaline in the brain has long been implicated in opiate withdrawal, but it has not been clear which noradrenergic systems are involved. Here we show that microinjection of beta-noradrenergic-receptor antagonists, or of an alpha2-receptor agonist, into the bed nucleus of the stria terminalis (BNST) in rats markedly attenuates opiate-withdrawal-induced conditioned place aversion. Immunohistochemical studies revealed that numerous BNST-projecting cells in the A1 and A2 noradrenergic cell groups of the caudal medulla were activated during withdrawal. Lesion of these ascending medullary projections also greatly reduced opiate-withdrawal-induced place aversion, whereas lesion of locus coeruleus noradrenergic projections had no effect on opiate-withdrawal behaviour. We conclude that noradrenergic inputs to the BNST from the caudal medulla are critically involved in the aversiveness of opiate withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, the stress-induced reinstatement of drug-related responding in animal models appears to depend on the activation of both CRF and norepinephrine in elements of the extended amygdala (ie, central nucleus of the amygdala and bed nucleus of the stria terminalis; tables 1, 2, circuits 16 and 17)22,33,53,96–98 and the ventral tegmental area (tables 1, 2, circuit 9).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
In the citing paper
“As tolerance and withdrawal develop, brain stress systems, such as CRF, norepinephrine, and dynorphin, are recruited in the extended amygdala and contribute to the development of negative emotional states in withdrawal and protracted abstinence (tables 1, 2, circuits 6–8).”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [22]
Citations
Cites
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,151
Paxinos, G. (1985) · Cited by 3,715
Clonidine blocks acute opiate-withdrawal symptoms
Gold, M., Redmond, D. E., & Kleber, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92823-4 · Cited by 710
Stinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Pothos, E., Rada, P., Mark, G. P., & Hoebel, B. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)91724-f · Cited by 288 · cited 1×
“Increased noradrenaline during opiate withdrawal has also been linked to decreased dopamine in the NA”
BackgroundSchulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285
The Lower Brainstem and Bodily Homeostasis
Loewy, A. D. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01234-x · Cited by 260
The Lower Brainstem and Bodily Homeostasis
Blessing, W. W. (1997) · Cited by 254
Tejani-Butt, S. M. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11249-4 · Cited by 239
Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome
Harris, G. C., & Aston-Jones, G. (1994) · Nature · doi:10.1038/371155a0 · Cited by 214
Self-citation
Research works printed but not linked: 2
- Akaoka, H., Zhu, Y., Shipley, M. T. & Aston-Jones, G. Expression of fos protein in central catecholamine neurons during opiate withdrawal. Soc. Neurosci. Abstr. 18, 374 (1992).
- McKittrick, C. R., Delfs, J. M., Aston-Jones, G. & Abercrombie, E. D. Differential spontaneous and withdrawal-induced efflux of catecholamines in nucleus accumbens shell of morphine-treated rats. Soc. Neurosci. Abstr. 25, 948 (1999).
Cited by
Items 101–200 of 491
Laviolette, S. R., Nader, K., & van der Kooy, D. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00327-8 · Cited by 117
Wang, X., Cen, X., & Lü, L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01487-x · Cited by 117
Inputs to the ventrolateral bed nucleus of the stria terminalis
Shin, J., Geerling, J. C., & Loewy, A. D. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21870 · Cited by 115
“In rats, stress-conditioned responses and behaviors associated with opiate administration and withdrawal are dependent on the activation of BSTvl-projecting A1/A2 noradrenergic neurons in rats (Delfs et al., 2000; Wang et al., 2001).”
BackgroundHedonic homeostatic dysregulation as a driver of drug-seeking behavior
Koob, G. F. (2008) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2009.04.002 · Cited by 114
Grueter, B. A., Gosnell, H. B., Olsen, C. M., Schramm-Sapyta, N. L., Nekrasova, T., Landreth, G. E., & Winder, D. G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0170-06.2006 · Cited by 114
Trinh, J. V., Nehrenberg, D. L., Jacobsen, J. P. R., Caron, M. G., & Wetsel, W. C. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00165-9 · Cited by 113
The intersection of stress and reward: BNST modulation of aversive and appetitive states
Ch'ng, S., Fu, J., Brown, R. M., McDougall, S. J., & Lawrence, A. J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.01.005 · Cited by 112
Aldosterone-sensitive neurons in the nucleus of the solitary tract: Efferent projections
Geerling, J. C., & Loewy, A. D. (2006) · The Journal of Comparative Neurology · doi:10.1002/cne.20993 · Cited by 111
Park, J., Kile, B. M., & Mark Wightman, R. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07005.x · Cited by 108
Pardon, M., Ma, S., & Morilak, D. A. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02355-2 · Cited by 107
Jalabert, M., Aston-Jones, G., Herzog, E., Manzoni, O., & Georges, F. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.010 · Cited by 103
Self-citationConditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal
Azar, M. R., Jones, B. C., & Schulteis, G. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1514-y · Cited by 101
Harris, G. C., & Aston‐Jones, G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300037 · Cited by 101
Self-citationEffects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats
Gilpin, N. W., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1967-8 · Cited by 99
Anhedonia, Hyperkatifeia, and Negative Reinforcement in Substance Use Disorders
Koob, G. F. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_288 · Cited by 99
Stewart, J. (2003) · American Journal on Addictions · doi:10.1080/10550490390143330-1 · Cited by 97
Neuroclinical Framework for the Role of Stress in Addiction
Kwako, L. E., & Koob, G. F. (2017) · Chronic Stress · doi:10.1177/2470547017698140 · Cited by 95
Pharmacokinetic Optimisation of Sustained-Release Bupropion for Smoking Cessation
Johnston, A. J., Ascher, J. A., Leadbetter, R. A., Schmith, V. D., Patel, D. K., Durcan, M. J., & Bentley, B. (2002) · Drugs · doi:10.2165/00003495-200262002-00002 · Cited by 95
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Neurocircuitry for modeling drug effects
Noori, H. R., Spanagel, R., & Hansson, A. C. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00485.x · Cited by 91
Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M. (2002) · Japanese Journal of Pharmacology · doi:10.1254/jjp.88.399 · Cited by 91
Khoshbouei, H., Cecchi, M., & Morilak, D. A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00424-9 · Cited by 91
Francesconi, W., Berton, F., Repunte-Canonigo, V., Hagihara, K., Thurbon, D., Lekic, D., Specio, S. E., Greenwell, T. N., Chen, S. A., Rice, K. C., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5129-08.2009 · Cited by 90
A final common pathway for depression? Progress toward a general conceptual framework
Stone, E. A., Lin, Y., & Quartermain, D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.08.007 · Cited by 89
Harris, G. C. M., & Aston‐Jones, G. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.012 · Cited by 88
Self-citationVaccarino, A. L., & Kastin, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00566-6 · Cited by 88
Buffalari, D. M., & See, R. E. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2008-3 · Cited by 87
Marcinkiewcz, C. A., Prado, M. M., Isaac, S. K., Marshall, A., Rylkova, D., & Bruijnzeel, A. W. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.231 · Cited by 87
Koob, G. F. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4484-6 · Cited by 87
Distribution of norepinephrine transporters in the non-human primate brain
Smith, H. R., Beveridge, T. J. R., & Porrino, L. J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.033 · Cited by 86
Park, J., Wheeler, R. A., Fontillas, K., Keithley, R. B., Carelli, R. M., & Wightman, R. M. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.10.017 · Cited by 85
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders
Carvalho, A. F., & Bockstaele, E. J. V. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.008 · Cited by 84
Grueter, B. A., & Winder, D. G. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300672 · Cited by 84
Richardson, K. A., & Aston-Jones, G. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3917-11.2012 · Cited by 83
Self-citationKrüger, O., Shiozawa, T., Kreifelts, B., Scheffler, K., & Ethofer, T. (2015) · Cortex · doi:10.1016/j.cortex.2015.02.007 · Cited by 81
Refractory dependence on opioid analgesics
Ballantyne, J. C., Sullivan, M. D., & Koob, G. F. (2019) · Pain · doi:10.1097/j.pain.0000000000001680 · Cited by 81
Massi, L., Elezgarai, I., Puente, N., Reguero, L., Grandes, P., Manzoni, O. J., & Georges, F. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2291-08.2008 · Cited by 81
Vagal Interoceptive Modulation of Motivated Behavior
Maniscalco, J. W., & Rinaman, L. (2018) · Physiology · doi:10.1152/physiol.00036.2017 · Cited by 81
Dayas, C. V., & Day, T. A. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.02011.x · Cited by 80
Norepinephrine Activates Dopamine D4Receptors in the Rat Lateral Habenula
Root, D. H., Hoffman, A. F., Good, C. H., Zhang, S., Gigante, E., Lupica, C. R., & Morales, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4525-13.2015 · Cited by 80
Erb, S. M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.11.025 · Cited by 80
Koob, G. F. (2011) · Focus · doi:10.1176/foc.9.1.foc55 · Cited by 79
Harris, G. C., & Aston‐Jones, G. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300122 · Cited by 79
Self-citationStimulant and reinforcing effects of cocaine in monoamine transporter knockout mice
Rocha, B. A. G. (2003) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2003.08.061 · Cited by 79
Morilak, D. A., Cecchi, M., & Khoshbouei, H. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00392-8 · Cited by 78
Banihashemi, L., & Rinaman, L. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3561-06.2006 · Cited by 77
Pantazis, C. B., Gonzalez, L. A., Tunstall, B. J., Carmack, S. A., Koob, G. F., & Vendruscolo, L. F. (2021) · Science Advances · doi:10.1126/sciadv.abf0364 · Cited by 77
Chaijale, N., Curtis, A. L., Wood, S. K., Zhang, X.-Y., Bhatnagar, S., Reyes, B. A. S., Bockstaele, E. J. V., & Valentino, R. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.117 · Cited by 77
Zhang, Z., & Schulteis, G. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.013 · Cited by 77
Crane, J. W., Buller, K. M., & Day, T. A. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10918 · Cited by 76
Fuentealba, J. A., Forray, M. I., & Gysling, K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750741.x · Cited by 74
Erb, S., Shaham, Y., & Stewart, J. (2001) · Stress · doi:10.3109/10253890109014753 · Cited by 73
“line in the ventral BNST is critical in the mediation of opiate withdrawal-induced aversion (Delfs et al., 2000).”
BackgroundVranjkovic, O., Gasser, P. J., Gerndt, C. H., Baker, D. A., & Mantsch, J. R. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0680-14.2014 · Cited by 73
Hogle, J. M., Kaye, J. T., & Curtin, J. J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.003 · Cited by 73
Pompolo, S., Rawson, J. A., & Clarke, I. J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02372-1 · Cited by 73
Absence and Rescue of Morphine Withdrawal in GIRK/Kir3 Knock-out Mice
Cruz, H. G., Berton, F., Sollini, M., Blanchet, C., Pravetoni, M., Wickman, K., & Lüscher, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0267-08.2008 · Cited by 72
Modulation of glutamatergic synaptic transmission in the bed nucleus of the stria terminalis
McElligott, Z. A., & Winder, D. G. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.05.022 · Cited by 72
Egli, R. E., & Winder, D. G. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00228.2003 · Cited by 72
Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., & Satoh, M. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1504-0 · Cited by 71
“2001), suggesting that the CeA might regulate the function of the BNST, which is also known to be clearly involved in stressful and aversive behavior (Henke 1984; Casada and Dafny 1991; Delfs et al. 2000).”
BackgroundInfluentialDeyama, S., Katayama, T., Ohno, A., Nakagawa, T., Kaneko, S., Yamaguchi, T., Yoshioka, M., & Minami, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1480-08.2008 · Cited by 71
Negus, S. S., & Rice, K. C. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.127 · Cited by 70
“…of clonidine or the related a-2 agonist ST-91 in rats attenuated acquisition of withdrawal-induced place aversions (Schulteis et al, 1998; Delfs et al, 2000) and withdrawal-induced suppression of responding maintained by food or electrical brain stimulation (Sparber and Meyer, 1978;…”
Zachariou, V., Liu, R., LaPlant, Q., Xiao, G., Renthal, W., Chan, G. C., Storm, D. R., Aghajanian, G., & Nestler, E. J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.021 · Cited by 70
Addictions Neuroclinical Assessment: A reverse translational approach
Kwako, L. E., Momenan, R., Grodin, E. N., Litten, R. Z., Koob, G. F., & Goldman, D. A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.03.006 · Cited by 70
The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10
Laurent, P., Becker, J. A. J., Valverde, O., Ledent, C. A., d’Exaerde, A. D. K., Schiffmann, S. N., Maldonado, R. J., Vassart, G., & Parmentier, M. (2005) · Nature Neuroscience · doi:10.1038/nn1585 · Cited by 69
Shields, A. D., Wang, Q., & Winder, D. G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.06.022 · Cited by 68
Greenwell, T. N., Walker, B. M., Cottone, P., Zorrilla, E. P., & Koob, G. F. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.012 · Cited by 68
Hou, Y., Lu, B., Li, M., Liu, Y., Chen, J., Chi, Z., & Liu, J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1970-09.2009 · Cited by 68
Geerling, J. C., & Loewy, A. D. (2007) · Journal of Comparative Neurology · doi:10.1002/cne.21452 · Cited by 67
Nakagawa, T., Yamamoto, R., Fujio, M., Suzuki, Y., Minami, M., Satoh, M., & Kaneko, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.029 · Cited by 67
Georges, F. E., Stinus, L., & Moine, C. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01334.x · Cited by 66
Li, Y., Wang, H., Qi, K., Chen, X., Li, S., Sui, N., & Kirouac, G. J. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.10.006 · Cited by 65
Laorden, M. L., Núñez, C., Almela, P., & Milanés, M. V. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01123.x · Cited by 65
Al‐Hasani, R., McCall, J. G., Foshage, A. M., & Bruchas, M. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.151 · Cited by 65
Radley, J. J., Anderson, R. M., Cosme, C. V., Glanz, R. M., Miller, M. C., Romig‐Martin, S. A., & LaLumiere, R. T. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4961-14.2015 · Cited by 65
Nobis, W. P., Kash, T. L., Silberman, Y., & Winder, D. G. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.030 · Cited by 64
Bupropion for the treatment of nicotine withdrawal and craving
Mooney, M. E., & Sofuoglu, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.965 · Cited by 64
Deyama, S., Nakagawa, T., Kaneko, S., Uehara, T., & Minami, M. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.021 · Cited by 64
Ketamine Blocks Morphine-Induced Conditioned Place Preference and Anxiety-Like Behaviors in Mice
McKendrick, G., Garrett, H., Jones, H. E., McDevitt, D. S., Sharma, S., Silberman, Y., & Graziane, N. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00075 · Cited by 64
Ma, S., & Morilak, D. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.12.028 · Cited by 64
Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal
Harris, A. C., & Gewirtz, J. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2155-0 · Cited by 63
Bie, B., Fields, H. L., Williams, J. T., & Pan, Z. Z. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-21-07950.2003 · Cited by 63
Bases neurobiológicas de la drogadicción
Fernández‐Espejo, E. (2002) · Revista de Neurología · doi:10.33588/rn.3407.2001437 · Cited by 63
Genetic clues to the molecular basis of tobacco addiction and progress towards personalized therapy
Walton, R. T., Johnstone, E. C., Munafo, M. R., Neville, M. J., & Griffiths, S. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)01915-3 · Cited by 63
Noradrenergic control of the bed nucleus of the stria terminalis in stress and reward
Flavin, S. A., & Winder, D. G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.02.013 · Cited by 62
Vathy, I., Šlamberová, R., Rimanóczy, Á., Riley, M. A., & Bar, N. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00355-x · Cited by 62
Monoaminergic innervation of the macaque extended amygdala
Freedman, L. J., & Shi, C. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00157-9 · Cited by 62
McElligott, Z. A., Fox, M. E., Walsh, P. L., Urban, D. J., Ferrel, M. S., Roth, B. L., & Wightman, R. M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.63 · Cited by 61
Schweimer, J. V., Fendt, M., & Schnitzler, H. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.044 · Cited by 61
Massaly, N., Morón, J. A., & Al-Hasani, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00480 · Cited by 59
“Recent evidence shows that the stress-induced dopamine release in the NAc is inhibited when corticotrophin releasing hormone (CRH) receptor antagonists are injected into the VTA (Holly et al., 2015), confirming the involvement of stress-induced hormones in the control of dopamine efflux from the VTA to the NAc.”
BackgroundBruijnzeel, A. W., Ford, J., Rogers, J. A., Scheick, S., Ji, Y., Bishnoi, M., & Alexander, J. C. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.12.001 · Cited by 59
Frenois, F., Moine, C. L., & Cador, M. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.255 · Cited by 58
Carelli, R. M., & West, E. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.025 · Cited by 57
Krawczyk, M., Georges, F., Sharma, R., Mason, X., Berthet, A., Bézard, E., & Dumont, É. C. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00710.2010 · Cited by 57
Beveridge, T. J. R., Smith, H. R., Nader, M. A., & Porrino, L. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2162-1 · Cited by 57
Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models
Renoir, T., Pang, T. Y., & Lanfumey, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.003 · Cited by 57
Puente, N., Elezgarai, I., Lafourcade, M., Reguero, L., Marsicano, G., Georges, F., Manzoni, O. J., & Grandes, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008869 · Cited by 56
Núñez, C., Földes, A., Pérez-Flores, D., García-Borrón, J. C., Laorden, M. L., Kovács, K., & Milanés, M. V. (2009) · Endocrinology · doi:10.1210/en.2008-1732 · Cited by 56
Laorden, M. L., Ferenczi, S., Pintér-Kübler, B., González-Martín, L. L., Lasheras, M. C., Kovács, K. J., Milanés, M. V., & Núñez, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036871 · Cited by 55
“The NTS-A2 cell group, the main noradrenergic cell group innervating the brain stress system [8], is also activated after naloxone-precipitated opiate withdrawal.”
BackgroundHerr, N. R., Park, J., McElligott, Z. A., Belle, A. M., Carelli, R. M., & Wightman, R. M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00620.2011 · Cited by 55
Metadata
- Authors
- Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G.
- Affiliations
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
- Venue
- Nature
- Published
- 2000-01
- Volume
- 403
- Issue
- 6768
- Pages
- 430-434
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1659240124
- Semantic Scholar
- 973cb279566f11006ae21f697af863157189bf18
- Cited by
- 462
- References
- 31
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 3 · 2023: 16 · 2022: 12 · 2021: 10 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 11 · 2016: 12 · 2015: 18 · 2014: 8 · 2013: 18 · 2012: 24
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- norepinephrine, opioid withdrawal, conditioned place aversion, bed nucleus of the stria terminalis, caudal medulla, noradrenergic projections, alpha-2 adrenergic agonists, locus coeruleus, ventral forebrain, aversive conditioning
- MeSH terms
- Adrenergic alpha-Agonists, Adrenergic beta-Antagonists, Amygdala, Animals, Clonidine, Male, Narcotics, Neurons, Afferent, Norepinephrine, Propanolamines, Propranolol, Substance Withdrawal Syndrome, Tyrosine 3-Monooxygenase, Betaxolol, Prosencephalon, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.